Alerts will be sent to your verified email
Verify Email
AVIVA
|
Aviva Inds
|
Sirohia & Sons
|
Brawn Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-0.14 % | -0.26 % | -11.92 % |
|
5yr Avg Net Profit Margin
|
-0.13 % | -2273.69 % | -6.0 % |
|
Price to Book
|
2.31 | 0.0 | 2.08 |
|
P/E
|
0.0 | 180.81 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
56.48 Days | 0.0 | 67.06 Days |
|
5yr Average Interest Coverage Ratio
|
1.59 | 148.06 | -18.52 |
|
5yr Avg ROCE
|
0.04 % | -0.02 % | -10.05 % |
|
5yr Avg Operating Profit Margin
|
-0.19 % | -2677.69 % | -6.76 % |
|
5 yr average Debt to Equity
|
0.16 | 0.01 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | n/a | n/a |
|
5yr Average Return on Assets
|
-0.1 % | -0.25 % | -5.5 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
65.3 % | 50.11 % | 53.66 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 4.98 % | -0.07 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -0.24 % |
|
Aviva Inds
|
Sirohia & Sons
|
Brawn Biotech
|
|---|